Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



ACKERMANN CHRISTINA Create: Alert

All | News | Filings
Date FiledTypeDescription
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/27/2022 4 ACKERMANN CHRISTINA (Please see remarks) has filed a Form 4 on Bausch & Lomb Corp
Txns: Granted 35,000 shares @ $0
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/09/2022 4 ACKERMANN CHRISTINA (Please see remarks) has filed a Form 4 on Bausch & Lomb Corp
Txns: Granted 83,333 shares @ $0
Granted 329,670 options to buy @ $18, valued at $5.9M
03/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/31/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/28/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/31/2020 4 ACKERMANN CHRISTINA (EVP AND GENERAL COUNSEL) has filed a Form 4 on Bausch Health Companies Inc.
Txns: Granted 28,171 shares @ $0
03/11/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/28/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/09/2020 4 ACKERMANN CHRISTINA (EVP AND GENERAL COUNSEL) has filed a Form 4 on Bausch Health Companies Inc.
Txns: Paid exercise price by delivering 3,360 shares @ $29.42, valued at $98.9k
08/13/2019 4 ACKERMANN CHRISTINA (EVP AND GENERAL COUNSEL) has filed a Form 4 on Bausch Health Companies Inc.
Txns: Paid exercise price by delivering 7,779 shares @ $22.39, valued at $174.2k
Sold 3,418 shares @ $22.4475, valued at $76.7k
07/15/2019 4 ACKERMANN CHRISTINA (EVP AND GENERAL COUNSEL) has filed a Form 4 on Bausch Health Companies Inc.
Txns: Sold 3,968 shares @ $24.81, valued at $98.4k
03/12/2019 4 ACKERMANN CHRISTINA (EVP AND GENERAL COUNSEL) has filed a Form 4 on Bausch Health Companies Inc.
Txns: Paid exercise price by delivering 3,630 shares @ $23.56, valued at $85.5k
03/01/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2019 4 ACKERMANN CHRISTINA (EVP AND GENERAL COUNSEL) has filed a Form 4 on Bausch Health Companies Inc.
Txns: Paid exercise price by delivering 3,446 shares @ $21.25, valued at $73.2k
10/17/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/13/2018 4 ACKERMANN CHRISTINA (EVP AND GENERAL COUNSEL) has filed a Form 4 on Bausch Health Companies Inc.
Txns: Paid exercise price by delivering 7,779 shares @ $23.52, valued at $183k
03/09/2018 4 ACKERMANN CHRISTINA (EVP AND GENERAL COUNSEL) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.
Txns: Granted 20,457 shares @ $0
Granted 60,853 options to buy @ $15.32, valued at $932.3k
Granted 13,638 options to buy @ $0
01/09/2018 4 ACKERMANN CHRISTINA (EVP AND GENERAL COUNSEL) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.
Txns: Paid exercise price by delivering 3,649 shares @ $23.85, valued at $87k
08/11/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/10/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
08/12/2016 4 ACKERMANN CHRISTINA (EVP and General Counsel) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.
Txns: Granted 39,469 options to buy @ $27.32, valued at $1.1M

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy